Patents by Inventor Connor Austin PARKER

Connor Austin PARKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic inhibitors of PTPN11
    Patent number: 10851110
    Abstract: The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: December 1, 2020
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Philip Jones, Barbara Czako, Jason Cross, Paul Leonard, Faika Mseeh, Connor Austin Parker
  • HETEROCYCLIC INHIBITORS OF PTPN11
    Publication number: 20190270746
    Abstract: The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
    Type: Application
    Filed: February 7, 2019
    Publication date: September 5, 2019
    Inventors: Philip JONES, Barbara CZAKO, Jason CROSS, Paul LEONARD, Faika MSEEH, Connor Austin PARKER
  • Heterocyclic inhibitors of PTPN11
    Patent number: 10280171
    Abstract: The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: May 7, 2019
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Philip Jones, Barbara Czako, Jason Cross, Paul Leonard, Faika Mseeh, Connor Austin Parker
  • HETEROCYCLIC INHIBITORS OF PTPN11
    Publication number: 20170342078
    Abstract: The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Philip JONES, Barbara CZAKO, Jason CROSS, Paul LEONARD, Faika MSEEH, Connor Austin PARKER